Kabloom, Ltd. – Trademark Portfolio

Entity Type: 03

Kabloom, Ltd. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes. The owner is based in Woburn, MA.

200 Wildwood Avenue

Woburn, MA 01801

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Kabloom, Ltd.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (6 filings)

Advertising; business management; business administration; office functions

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

4
Lubricants & Fuels (1 filing)

Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Kabloom, Ltd. have?

Kabloom, Ltd. has 10 U.S. trademarks filed with the USPTO.

What trademark classes does Kabloom, Ltd. file in?

Kabloom, Ltd. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 4 (Lubricants & Fuels), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.

What is Kabloom, Ltd.'s trademark registration success rate?

Kabloom, Ltd. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.